SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016079
Filing Date
2019-05-07
Accepted
2019-05-06 18:24:54
Documents
73
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20190331.htm 10-Q 2033837
2 EX-10.1 rare-ex101_269.htm EX-10.1 23927
3 EX-10.2 rare-ex102_270.htm EX-10.2 38634
4 EX-10.3 rare-ex103_268.htm EX-10.3 45170
5 EX-10.4 rare-ex104_267.htm EX-10.4 30843
6 EX-31.1 rare-ex311_8.htm EX-31.1 17452
7 EX-31.2 rare-ex312_6.htm EX-31.2 17451
8 EX-32.1 rare-ex321_7.htm EX-32.1 10873
9 GRAPHIC gott1f35wdv0000001.jpg GRAPHIC 41305
  Complete submission text file 0001564590-19-016079.txt   6328462

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT rare-20190331.xml EX-101.INS 1187759
11 XBRL TAXONOMY EXTENSION SCHEMA rare-20190331.xsd EX-101.SCH 49315
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20190331_cal.xml EX-101.CAL 59162
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20190331_def.xml EX-101.DEF 130849
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20190331_lab.xml EX-101.LAB 333323
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20190331_pre.xml EX-101.PRE 259935
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 19800720
SIC: 2834 Pharmaceutical Preparations